KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Receivables (2020 - 2025)

Organon has reported Receivables over the past 6 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Receivables at $1.3 billion for Q4 2025, down 1.99% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (down 1.99% YoY), and the annual figure for FY2025 was $1.3 billion, down 1.99%.
  • Receivables for Q4 2025 was $1.3 billion at Organon, down from $1.5 billion in the prior quarter.
  • Over the last five years, Receivables for OGN hit a ceiling of $2.5 billion in Q2 2021 and a floor of $1.0 billion in Q1 2021.
  • Median Receivables over the past 5 years was $1.7 billion (2022), compared with a mean of $1.7 billion.
  • Peak annual rise in Receivables hit 66.34% in 2022, while the deepest fall reached 23.22% in 2022.
  • Organon's Receivables stood at $1.8 billion in 2021, then rose by 3.59% to $1.8 billion in 2022, then fell by 5.68% to $1.7 billion in 2023, then decreased by 22.13% to $1.4 billion in 2024, then decreased by 1.99% to $1.3 billion in 2025.
  • The last three reported values for Receivables were $1.3 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.